We found that the expression of VDAC1 in HL-60 cells decreased after the combined treatment with ATRA (10 nM) and MEL, indicating changes in the regulation of metabolic and energetic functions of mitochondria and in the fate of cancer cells. The gene discussed is VDAC1; the disease is cancer.